5-HT2C receptor gene polymorphisms associated with antipsychotic drug action alter promoter activity
- PMID: 17376412
- DOI: 10.1016/j.brainres.2007.02.038
5-HT2C receptor gene polymorphisms associated with antipsychotic drug action alter promoter activity
Abstract
Polymorphisms within the 5-HT(2C) receptor gene promoter have been associated with several physiological and psychiatric phenotypes. Notably, the -759T allele has been associated with resistance to antipsychotic induced weight gain. This study assessed the activity of four promoter haplotypes expressed as luciferase constructs in the SH-SY5Y human neuroblastoma cell line in the presence or absence of a constitutively active 5-HT(2C) receptor. The presence of either -759T or -697C alleles reduced promoter activity. In addition a haplotype associated with resistance to antipsychotic induced weight showed under activity compared to the most common haplotype. In the presence of the 5-HT(2C) receptor a similar pattern of promoter activity was observed. Both -759C/T and -697G/C polymorphic sites are likely to play a role in basal promoter activity. Resistance to weight gain may, in part, be mediated by the consequences of reduced 5-HT(2C) receptor expression.
Similar articles
-
[Association of HTR2C-759C/T and -697G/C polymorphisms with antipsychotic agent-induced weight gain].Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008 Apr;33(4):312-5. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008. PMID: 18460774 Chinese.
-
The 5-HT2C receptor and antipsychoticinduced weight gain - mechanisms and genetics.J Psychopharmacol. 2006 Jul;20(4 Suppl):15-8. doi: 10.1177/1359786806066040. J Psychopharmacol. 2006. PMID: 16785265 Review.
-
[Association of antipsychotic agent-induced weight gain with a polymorphism of the promotor region of the 5-HT2C receptor gene].Zhonghua Yi Xue Za Zhi. 2002 Aug 25;82(16):1097-101. Zhonghua Yi Xue Za Zhi. 2002. PMID: 12425817 Chinese.
-
-759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment.Prog Neuropsychopharmacol Biol Psychiatry. 2007 Apr 13;31(3):673-7. doi: 10.1016/j.pnpbp.2006.12.021. Epub 2007 Jan 12. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17275977 Clinical Trial.
-
The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment.Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jul;29(6):1021-8. doi: 10.1016/j.pnpbp.2005.03.019. Prog Neuropsychopharmacol Biol Psychiatry. 2005. PMID: 15953671 Review.
Cited by
-
Pharmacogenetic Aspects of Antipsychotic Drug-induced Weight Gain - A Critical Review.Clin Psychopharmacol Neurosci. 2012 Aug;10(2):71-7. doi: 10.9758/cpn.2012.10.2.71. Epub 2012 Aug 31. Clin Psychopharmacol Neurosci. 2012. PMID: 23431082 Free PMC article.
-
Genetic and biochemical changes of the serotonergic system in migraine pathobiology.J Headache Pain. 2017 Dec;18(1):20. doi: 10.1186/s10194-016-0711-0. Epub 2017 Feb 13. J Headache Pain. 2017. PMID: 28194570 Free PMC article. Review.
-
Pharmacogenetics and outcome with antipsychotic drugs.Dialogues Clin Neurosci. 2014 Dec;16(4):555-66. doi: 10.31887/DCNS.2014.16.4/jpouget. Dialogues Clin Neurosci. 2014. PMID: 25733959 Free PMC article. Review.
-
Genetics of Common Antipsychotic-Induced Adverse Effects.Mol Neuropsychiatry. 2016 Jul;2(2):61-78. doi: 10.1159/000445802. Epub 2016 May 20. Mol Neuropsychiatry. 2016. PMID: 27606321 Free PMC article. Review.
-
Mechanistic intersections between migraine and major depressive disorder.J Headache Pain. 2025 Jul 9;26(1):157. doi: 10.1186/s10194-025-02097-x. J Headache Pain. 2025. PMID: 40634879 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources